Gmo Emerging Correlations

GMAUX Fund  USD 11.81  0.04  0.34%   
The current 90-days correlation between Gmo Emerging Markets and Delaware Limited Term Diversified is -0.12 (i.e., Good diversification). The correlation of Gmo Emerging is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Gmo Emerging Correlation With Market

Significant diversification

The correlation between Gmo Emerging Markets and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Gmo Emerging Markets and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gmo Emerging Markets. Also, note that the market value of any mutual fund could be closely tied with the direction of predictive economic indicators such as signals in employment.

Moving together with Gmo Mutual Fund

  0.64GEACX Gmo TrustPairCorr
  0.81GMAQX Gmo Emerging MarketsPairCorr

Moving against Gmo Mutual Fund

  0.38GUGAX Gmo E PlusPairCorr
  0.33GUSTX Gmo TreasuryPairCorr
  0.45GMOHX Gmo Opportunistic IncomePairCorr
  0.4GMODX Gmo Opportunistic IncomePairCorr
  0.4GMOLX Gmo Opportunistic IncomePairCorr
  0.45GAAAX Gmo Opportunistic IncomePairCorr
  0.43GPBFX Gmo E PlusPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Gmo Mutual Fund performing well and Gmo Emerging Mutual Fund doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Gmo Emerging's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.